•
Mar 31, 2016

EyePoint Pharmaceuticals Q3 2016 Earnings Report

Total Revenue
$324K
Previous year: $328K
-1.2%
EPS
-$1.5
Previous year: -$1.7
-11.8%
Gross Profit
-$2.75M
Previous year: -$3.01M
-8.7%
Cash and Equivalents
$24.9M
Previous year: $23M
+8.1%
Total Assets
$36.2M
Previous year: $35.7M
+1.3%

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals